AU2013224734B2 - Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof - Google Patents

Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof

Info

Publication number
AU2013224734B2
AU2013224734B2 AU2013224734A AU2013224734A AU2013224734B2 AU 2013224734 B2 AU2013224734 B2 AU 2013224734B2 AU 2013224734 A AU2013224734 A AU 2013224734A AU 2013224734 A AU2013224734 A AU 2013224734A AU 2013224734 B2 AU2013224734 B2 AU 2013224734B2
Authority
AU
Australia
Prior art keywords
subtype
monoclonal antibodies
neuraminidase
influenza virus
subtypes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2013224734A
Other versions
AU2013224734A1 (en
Inventor
Fang He
Hwei-Sing Kwang
Hong Liang Qian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temasek Life Sciences Laboratory Ltd
Original Assignee
Temasek Life Sciences Laboratory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008297594A external-priority patent/AU2008297594B2/en
Application filed by Temasek Life Sciences Laboratory Ltd filed Critical Temasek Life Sciences Laboratory Ltd
Priority to AU2013224734A priority Critical patent/AU2013224734B2/en
Publication of AU2013224734A1 publication Critical patent/AU2013224734A1/en
Application granted granted Critical
Publication of AU2013224734B2 publication Critical patent/AU2013224734B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Abstract of the Disclosure Monoclonal antibodies and related binding proteins that bind specifically to the envelope glycoprotein of H5 subtypes or neuraminidase glycoprotein of Ni subtypes of avian influenza virus (AIV) are provided. The monoclonal antibodies and related binding proteins are useful for the detection of H5 and Ni subtypes of AIV, including H5N1 subtypes and provide means for the diagnosis, surveillance and treatment of dangerous viral infections. 4642008_1 (GHMatters) P83602.AU.1
AU2013224734A 2007-09-13 2013-09-06 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof Ceased AU2013224734B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2013224734A AU2013224734B2 (en) 2007-09-13 2013-09-06 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60/972,059 2007-09-13
AU2008297594A AU2008297594B2 (en) 2007-09-13 2008-09-12 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
AU2013224734A AU2013224734B2 (en) 2007-09-13 2013-09-06 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2008297594A Division AU2008297594B2 (en) 2007-09-13 2008-09-12 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof

Publications (2)

Publication Number Publication Date
AU2013224734A1 AU2013224734A1 (en) 2013-10-03
AU2013224734B2 true AU2013224734B2 (en) 2016-07-14

Family

ID=49237907

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013224734A Ceased AU2013224734B2 (en) 2007-09-13 2013-09-06 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof

Country Status (1)

Country Link
AU (1) AU2013224734B2 (en)

Also Published As

Publication number Publication date
AU2013224734A1 (en) 2013-10-03

Similar Documents

Publication Publication Date Title
WO2009035420A8 (en) Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof
WO2007089753A3 (en) Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof
WO2009053604A3 (en) Influenza virus haemagglutinin-specific monoclonal antibodies
EP2363415A3 (en) H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance
WO2009035412A8 (en) Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof
WO2010010467A3 (en) Neutralizing anti-influenza a virus antibodies and uses thereof
WO2012096994A3 (en) Antibodies directed against influenza
NZ590115A (en) Monoclonal antibodies having homosubtype cross -neutralization properties against influenza a viruses subtype h1
NZ588238A (en) Monoclonal antibodies capable of reacting with a plurality of influenza virus a subtypes
NZ596032A (en) Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
WO2009014919A3 (en) H2n3 influenza a viruses and methods of use
HRP20130163T1 (en) Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
EP2174957A4 (en) Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof
WO2009026397A3 (en) Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods
EA201390806A1 (en) CONSTRUCTION OF PEPTIDE FRAME
MX2021004686A (en) Neutralizing anti-influenza a antibodies and uses thereof.
SG172333A1 (en) Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza a viruses and uses thereof
CL2008002092A1 (en) Conjugate containing two or more antifusogenic peptides and an anti-cd-4 antibody; Method of production; pharmaceutical composition comprising it; antifusogenic polypeptides and use of the conjugate to treat viral infections.
NZ702146A (en) Peptides derived from viral proteins for use as immunogens and dosage reactants
WO2016011035A8 (en) Neutralizing anti-influenza b antibodies and uses thereof
PL418671A1 (en) Monoclonal antibodies against haemagglutinin of influenza serotype H5 viruses and their applications, hybridomas that produce mentioned antibodies, compositions and diagnostic sets
MY160435A (en) A novel antiviral peptide against avian influenza virus h9n2
EP3959216A4 (en) Anti-influenza b virus neuraminidase antibodies and uses thereof
WO2009054708A3 (en) Antibody therapy for highly pathogenic avian influenza virus
WO2008064072A3 (en) Anti-tsg101 antibodies and their uses for treatment of viral infections

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired